期刊文献+

中医辨证分型治疗对美多巴增效减毒的影响 被引量:14

Effect of TCM Treatment According to Syndrome Differentiation in Enhancing Curative Effect and Reducing Side-effect of Madopa
在线阅读 下载PDF
导出
摘要 目的观察中医辨证分型治疗对帕金森病患者使用美多巴的减毒增效作用。方法共选择帕金森病患者101例进行前瞻性分层随机试验,其中强直少动型用帕病1号方加美多巴片(帕病1号组,22例)治疗,震颤型用帕病3号方加美多巴片(帕病3号组,30例)治疗,对照组采用中药协定方加美多巴片(49例)治疗。3组均以3个月为1个疗程。观察临床疗效及治疗前后帕金森病评定量表(UPDRS评分),并进行不良反应监测。结果治疗后,帕病3号组UPDRS评分各项积分和总分均有明显改善(P<0.01),帕病1号组、对照组各项积分明显改善(P<0.01),帕病1号组、帕病3号组的改善幅度优于对照组(P<0.01);帕病1号组、帕病3号组、对照组进步率分别为95.5%(21/22例)、100.0%(30/30例)和83.7%(45/49例),帕病1号组、帕病3号组优于对照组,差异有显著性(P<0.05)。帕病1号组治疗前后并发症积分差值与对照组比较,差异有显著性(P<0.05)。结论中医辨证分型治疗帕金森病能够改善症状、减少并发症,对美多巴有减毒增效的作用。 Objective To observe the effect of TCM treatment according to syndrome differentiation in enhancing curative effect and reducing side-effect of madopa in patients with Parkinson' s disease (PD), Methods The trial was conducted in 101 PD patients with a prospective stratified randomized and controlled method. They were assigned to group 1 in which the patients of rigidity were treated with Pabing Recipe 1 (PR1) plus Madopa tablets, group 2 with those of tremor given Pabing Recipe 3 (PR3) plus Madopa tablets, and group 3 given a fixed Chinese recipe plus Madopa tablets as the control. The treatment course for all the groups was 3 months. Clinical efficacy was evaluated with unified Parkinson's disease rating scale (UPDRS) and the adverse reactions observed before and after treatment. Results After treatment, the 4 partial scores and the total score of UPDRS decreased significantly in group 2 (P〈0. 01), and the former of them and the total score declined in group 1 and 3 (P〈0. 01), the improvement was better in group 1 and 2 than that in group 3 ( P 〈 0. 01) ; the improvement rate in group 1 to 3 was 95.5 %, 100.0 % and 83.7 %, respectively, which was significantly higher in group 1 and 2 than that in group 3 (P〈 0. 05). Conclusion TCM treatment according to syndrome differentiation could improve the clinical symptoms and reduce complications in PD patients, which could enhance curative effect and reduce side-effect of madopa.
机构地区 广东省中医院
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2007年第9期796-799,共4页 Chinese Journal of Integrated Traditional and Western Medicine
关键词 帕病1号方 帕病3号方 中西医结合治疗 帕金森病 减毒增效 Pabing Recipe 1 Pabing Recipe 3 treatment with integrated Chinese and Western medicine Parkinson's disease enhancing curative effect and reducing side-effect
  • 相关文献

参考文献10

二级参考文献22

  • 1张开.TUNEL法──细胞凋亡的组织化学鉴定法[J].日本医学介绍,1995,16(10):469-469. 被引量:11
  • 2刘道宽 蒋雨平 江澄川.锥体外系疚病[M].上海:上海科技出版社,2000.91.
  • 3Kastner A, Hirseh EC, Agid Y, et al. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease[J]. Brain Res, 1993 ;606:341-5.
  • 4Ungerstedt U,Arbthnott GW. Quantitative recording of rotational behavior in rots after 6-OHDA lesions the nigrostriatal dopamine system[ J]. Brian Res, 1970 ; 24:485-93,.
  • 5Carman LS, Gage GH, Shults CW. Partail lesion of the substantia nigra:relation, between extent of lesion and rotational behavior[ J]. Brian Res,1991 ;553:275-83.
  • 6Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex(ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody(PAP) procedures[J]. J Histochem Cytochem,1981 ;29:577-80.
  • 7Kastner A, Herrero MT, Hirsch EC, et al. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therapy[J]. Ann Neurol, 1994 ;36:206-14.
  • 8Ferraris N, Perroteau I, Marchis S, et al. Glutamatergic deafferentation of olfactory bulb modulates the expression of mGluRla Mrna [ J ]. Neuroreport,1997; 8: 1949-53.
  • 9Rodriguez-Gomez JA, Venero JL, Vizuete ML, et al. Deprenyl induced the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system[ J]. Mol Brain Res, 1997 ,46:31-8.
  • 10Rodriguez-Gomez JA, Romero-Ramos M, vizuete ML, et al. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine[ J ]. Mol Pharmacol, 1997;52:651-7.

共引文献603

同被引文献201

引证文献14

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部